<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharmacies Management System]]></title><description><![CDATA[pharmacyconsult]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/blog</link><generator>RSS for Node</generator><lastBuildDate>Wed, 15 Apr 2026 10:52:57 GMT</lastBuildDate><atom:link href="https://shaikhussam.wixsite.com/pharmacyconsult/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[CONGENITALLY ACQUIRED INFECTIONS (Treatment)]]></title><description><![CDATA[Herpes Simplex Virus: Treatment a. Management of neonates with symptomatic/proven HSV disease  i. Intravenous acyclovir (20 mg/kg/dose...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2018/03/04/congenitally-acquired-infections-treatment</link><guid isPermaLink="false">5fd88f0e8518c00017e027dd</guid><pubDate>Sun, 04 Mar 2018 06:24:45 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/11bbf712d7d34ce69ac5afafb3fea993.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[CONGENITALLY ACQUIRED INFECTIONS]]></title><description><![CDATA[Herpes Simplex Virus (HSV)  1. Background  a. HSV type 2 is the most common cause of neonatal herpes disease.  b. Transmission is usually...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2018/03/04/congenitally-acquired-infections</link><guid isPermaLink="false">5fd88f0e8518c00017e027dc</guid><pubDate>Sun, 04 Mar 2018 06:21:47 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/1b177e2785bf4335a23a427ddffa9471.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN]]></title><description><![CDATA[Targeted therapies: 1. Inhaled nitric oxide 2. Prostacyclin analogs – (Prostacyclin produces vasodilation by stimulating cyclic adenosine...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2018/02/03/persistent-pulmonary-hypertension-of-the-newborn-3</link><guid isPermaLink="false">5fd88f0e8518c00017e027db</guid><pubDate>Sat, 03 Feb 2018 15:03:53 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/5f507a_a49b5ec8b22040d9b282a35334eeedaa~mv2.jpg/v1/fit/w_275,h_183,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN (Treatment)]]></title><description><![CDATA[1. Goals: Maintain systemic blood pressure to overcome right-to-left shunt and decrease pulmonary  vascular resistance to facilitate...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2018/02/03/persistent-pulmonary-hypertension-of-the-newborn-treatment</link><guid isPermaLink="false">5fd88f0e4ab19b0017ec39a5</guid><pubDate>Sat, 03 Feb 2018 14:53:34 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/5f507a_721ad4d6dcae47b8b183569f0a771b74~mv2.jpg/v1/fit/w_425,h_283,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN]]></title><description><![CDATA[B. Clinical Presentation  1. Symptoms – Evidence of respiratory distress, tachypnea, oxygen desaturation, cyanosis  2. Oxygenation index...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2018/02/03/persistent-pulmonary-hypertension-of-the-newborn-1</link><guid isPermaLink="false">5fd88f0e4ab19b0017ec399f</guid><pubDate>Sat, 03 Feb 2018 13:56:29 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/f1c0b06cbe134987a7c7b6462a7aa3eb.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN]]></title><description><![CDATA[A. Background  1. Characterized by elevated pulmonary pressures after birth in conjunction with a right-to-left shunt  across the ductus...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2018/02/03/persistent-pulmonary-hypertension-of-the-newborn</link><guid isPermaLink="false">5fd88f0e4ab19b0017ec39a3</guid><pubDate>Sat, 03 Feb 2018 13:54:24 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/ec6fa99dee8541b2b3483400521483a9.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[NECROTIZING ENTEROCOLITIS Treatment]]></title><description><![CDATA[Antibiotics  i. The goals are to prevent ongoing GI mucosal injury, prevent translocation of enteric bacteria  into the bloodstream, and...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2018/01/09/necrotizing-enterocolitis-treatment</link><guid isPermaLink="false">5fd88f0e4ab19b0017ec39a7</guid><pubDate>Tue, 09 Jan 2018 19:03:11 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/1cc85cbea2ae49e3abdecbb7a4bc6904.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[NECROTIZING ENTEROCOLITIS]]></title><description><![CDATA[Background  1. Pathogenesis is multifactorial.  a. Immaturity of the GI tract is the most important factor.  i. Immaturity results in...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2018/01/09/necrotizing-enterocolitis</link><guid isPermaLink="false">5fd88f0e4ab19b0017ec39a6</guid><pubDate>Tue, 09 Jan 2018 18:48:24 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/2e869fbd40a64830ad04dda3fcb2370b.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[Patent Ductus Arteriosus (Treatment)]]></title><description><![CDATA[Treatment  1. Supportive care, including fluid restriction and respiratory support, may be sufficient to manage the  symptoms of PDA...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2017/12/17/patent-ductus-arteriosus-2</link><guid isPermaLink="false">5fd88f0e4ab19b0017ec39a1</guid><pubDate>Sun, 17 Dec 2017 19:24:01 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/5f507a_484a3ffe8ffa4d538380a4c760c0f0b3~mv2.jpg/v1/fit/w_828,h_876,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[Patent Ductus Arteriosus]]></title><description><![CDATA[Clinical Presentation  1. Symptoms – Murmur, hyperactive precordium, bounding pulses, widened pulse pressure, hypotension,  worsening...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2017/12/17/patent-ductus-arteriosus-1</link><guid isPermaLink="false">5fd88f0e4ab19b0017ec39a2</guid><pubDate>Sun, 17 Dec 2017 19:10:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/4970301561b245eda395bf8bd605bb4e.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[Patent Ductus Arteriosus]]></title><description><![CDATA[Background  1. The ductus arteriosus is a vessel connecting the pulmonary artery to the aorta that allows blood flow to  bypass the fetal...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2017/12/17/patent-ductus-arteriosus</link><guid isPermaLink="false">5fd88f0e4ab19b0017ec39a0</guid><pubDate>Sun, 17 Dec 2017 19:03:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/f7180e735a0ae77c7bf463d6cec7f42d.jpg/v1/fit/w_853,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[Intraventricular hemorrhage: (Prevention)]]></title><description><![CDATA[Prevention  1. Antenatal corticosteroids  a. Betamethasone  b. Although their primary indication is to promote fetal lung maturation,...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2017/12/16/intraventricular-hemorrhage-prevention</link><guid isPermaLink="false">5fd88f0e4ab19b0017ec39a4</guid><pubDate>Sat, 16 Dec 2017 18:52:20 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/a4d56202e0b84fe9ad98d9ba859b1ef2.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[Intraventricular hemorrhage]]></title><description><![CDATA[Clinical Presentation  1. Symptoms  a. Often asymptomatic – Up to 50% of cases  b. Symptoms may include rapid decline in hematocrit,...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2017/12/16/intraventricular-hemorrhage-1</link><guid isPermaLink="false">5fd88f0e4ab19b0017ec399e</guid><pubDate>Sat, 16 Dec 2017 18:37:52 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/0e851514ec6b4c868c40c8bd02808147.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[Intraventricular hemorrhage]]></title><description><![CDATA[Background  1. Mechanism of hemorrhage  a. Likely multifactorial b. Lack of cerebral pressure autoregulation resulting in an inability to...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2017/12/16/intraventricular-hemorrhage</link><guid isPermaLink="false">5fd88f0ee9bb9700177077e2</guid><pubDate>Sat, 16 Dec 2017 18:31:32 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/65caf121bc1f49029c25168f0073f026.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[Apnea of Prematurity (Treatment)]]></title><description><![CDATA[Methylxanthines (i.e., theophylline/aminophylline and caffeine)  a. Mechanism of action – Nonspecific inhibitor of adenosine receptors ...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2017/12/13/apnea-of-prematurity-treatment</link><guid isPermaLink="false">5fd88f0ee9bb9700177077de</guid><pubDate>Tue, 12 Dec 2017 23:07:45 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/5f507a_046614fc08084d699515e93bb9846fc6~mv2.jpg/v1/fit/w_828,h_203,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[Apnea of Prematurity]]></title><description><![CDATA[Clinical Presentation  1. Cessation of breathing for at least 20 seconds or the episode of apnea may be shorter if associated with ...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2017/12/13/apnea-of-prematurity</link><guid isPermaLink="false">5fd88f0ee9bb9700177077db</guid><pubDate>Tue, 12 Dec 2017 23:00:14 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/4970301561b245eda395bf8bd605bb4e.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[Apnea of Prematurity]]></title><description><![CDATA[An immature central respiratory drive, inability to maintain airway patency, and underdeveloped  respiratory muscles cause...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2017/12/13/apnea-of-prematurity-1</link><guid isPermaLink="false">5fd88f0ee9bb9700177077dc</guid><pubDate>Tue, 12 Dec 2017 22:46:04 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/a02a7d9e6ea54e0985c11cc536f79e83.jpg/v1/fit/w_960,h_675,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[Bronchopulmonary Dysplasia]]></title><description><![CDATA[Treatment : 1. Diuretics  a. Thiazide diuretics (e.g., hydrochlorothiazide), potassium-sparing diuretics (e.g., spironolactone),  and...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2017/12/05/bronchopulmonary-dysplasia-2</link><guid isPermaLink="false">5fd88f0ee9bb9700177077e3</guid><pubDate>Wed, 06 Dec 2017 20:39:00 GMT</pubDate><enclosure url="http://www.youtube.com/watch?v=mxyCZ2Jxyqg" length="0" type="video"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[Bronchopulmonary Dysplasia]]></title><description><![CDATA[Clinical Presentation  1. Tachypnea, retractions, shallow breathing, wheezing, increased oxygen requirement, and  bronchospasm may be...]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2017/12/05/bronchopulmonary-dysplasia-1</link><guid isPermaLink="false">5fd88f0ee9bb9700177077e1</guid><pubDate>Wed, 06 Dec 2017 20:16:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/1d656a70b01c4fee8c19e7708000fa57.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item><item><title><![CDATA[Bronchopulmonary Dysplasia]]></title><description><![CDATA[>Also known as chronic lung disease  >Significant risk of mortality and long-term morbidity  >Definition – “Old” versus “new” BPD. i....]]></description><link>https://shaikhussam.wixsite.com/pharmacyconsult/single-post/2017/12/05/bronchopulmonary-dysplasia</link><guid isPermaLink="false">5fd88f0ee9bb9700177077e0</guid><pubDate>Wed, 06 Dec 2017 19:58:00 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/700336b0db5c4e12bbc4345a0e4fdd40.jpg/v1/fit/w_1000,h_1000,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Lateef, H Shaikh</dc:creator></item></channel></rss>